Justify Rationality of FDC Meropenem plus Sodium Carbonate plus Avibactam: CDSCO Panel Tells Akum Pharmaceutical Dr. Divya Colin2 May 2024 6:00 PM ISTNew Delhi: Reviewing the proposal presented by the drug major Akum Pharmaceutical, the Subject Expert Committee (SEC) functional under the Central...
Alkem Laboratories Gets CDSCO Panel Nod to Study Amoxicillin,Clavulanate Powder for reconstitution into suspension Dr. Divya Colin1 May 2024 6:00 PM ISTNew Delhi: Reviewing the revised Phase IV clinical trial (CT) protocol of antimicrobial drug Amoxicillin Trihydrate plus Potassium Clavulanate powder...
Conduct bridging CT, prove efficacy, safety: CDSCO Panel Tells Glenmark on Roflumilast Cream of additional strength, indication Dr. Divya Colin30 April 2024 6:00 PM ISTNew Delhi: Citing that Glenmark Limited should conduct bridging clinical trials to prove the efficacy and safety of the Roflumilast Cream 0.3%w/w...
AstraZeneca Gets CDCSO Panel Nod to Import, market Eculizumab to treat Paroxysmal Nocturnal Hemoglobinuria Dr. Divya Colin29 April 2024 6:00 PM ISTNew Delhi: Noting that there is an unmet medical need in India, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Serum Institute of India's TB Detection tool rdESAT, rCFP-10 (Cy-Tb) use granted for 1 year age and above: CDSCO panel Dr. Divya Colin28 April 2024 6:00 PM ISTNew Delhi: Reviewing the clinical data of the comparative study of testing the efficacy and safety RdESAT-6 and rCFP-10 (Cy-Tb) injection, the Subject...
CDSCO panel rejects Pfizer Products India Local Clinical Trial Waiver Proposal for Elranatamab solution for injection Dr. Divya Colin27 April 2024 6:00 PM ISTNew Delhi: Reviewing the proposal presented by Pfizer Products India for grant of permission to import and market Elranatamab solution for injection...
Intas Pharmaceuticals Gets CDSCO Panel Nod to Study Trastuzumab Emtansine in Metastatic Breast Cancer Dr. Divya Colin26 April 2024 6:00 PM ISTNew Delhi: In a significant development, Intas Pharmaceuticals has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central...
Eli Lilly Gets CDSCO Panel Nod to Study Lepodisiran Dr. Divya Colin25 April 2024 6:00 PM ISTNew Delhi: The drug major Eli Lilly has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
There is nothing called multivitamin deficiency: Leading Diabetologist slams Haleon's Centrum Advertisement Farhat Nasim25 April 2024 11:50 AM ISTNew Delhi: Eminent diabetologist Padmashri Dr V Mohan recently took to social media platform X to rebuke a multivitamin advertisement, asserting that...
GSK Gets CDSCO Panel Nod to Study antimalarial drug Tafenoquine Dr. Divya Colin24 April 2024 6:00 PM ISTNew Delhi: The pharmaceutical major GSK has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Zydus Gets CDSCO Panel Nod To Manufacture Market Letermovir 240 mg, 480 mg Tablet Dr. Divya Colin23 April 2024 6:00 PM ISTNew Delhi: The drug major Zydus has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Trademark Tussle: HC bars Glenmark from using Indamet, says similar to Sun Pharma's anti-diabetes drug Istamet Farhat Nasim22 April 2024 2:44 PM ISTNew Delhi: In a major respite to Sun Pharma Laboratories Ltd. , the Delhi High Court has upheld its previous ruling from July, affirming the...
